Mary Brantner

Mary Brantner has extensive work experience in the pharmaceutical industry. Mary currently holds the position of Senior Director, Clinical Program Optimization at Insmed Incorporated, where they collaborate with cross-functional stakeholders to identify and address inefficiencies in business operations. Prior to this, they worked at Mallinckrodt Pharmaceuticals in various leadership roles, including Executive Director, Head of Global Development Operations and Senior Director, Head of Global Development Operations Process and Systems. At these positions, they were responsible for overseeing the planning, execution, and reporting of clinical development programs, as well as implementing strategies to manage project and program risks. Earlier in their career, Mary held top-level positions at Daiichi Sankyo, Inc., Yamanouchi Pharma America, Inc., Alteon Inc., and BD, where they gained experience in clinical trial management, clinical operations, and trial oversight. Overall, Mary Brantner has a strong background in clinical development operations and has demonstrated their expertise in optimizing processes and ensuring successful product development.

Mary Brantner has a Master's degree in Clinical Research Administration from New York Medical College and a Bachelor's degree in Biology from Ramapo College of New Jersey. Mary has additional certifications in Change Management from Prosci, obtained in 2017, and they are also a certified Clinical Research Professional (CCRP) from the Society of Clinical Research Associates (SOCRA), obtained in 2001. Additionally, they hold the certification of Clinical Research Associate (CCRA) from the Association of Clinical Research Professionals, obtained in 1999.